Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest thyroid cancer Stories

2014-01-29 23:04:46

The Firm is currently evaluating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, thyroid cancer, or pancreatitis due to their use of the Type 2 diabetes drugs. New York, New York (PRWEB) January 29, 2014 As Byetta lawsuits (http://www.byettalawsuit.com ) continue to mounts in courts around the country, Bernstein Liebhard LLP notes that plaintiffs in federally-filed lawsuits involving allegations that use of the drug caused thyroid cancer have filed a...

2014-01-25 23:02:06

The Firm is investigating Byetta lawsuits that allege an association between the use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer. New York, New York (PRWEB) January 25, 2014 Product liability claims alleging, among other things, an association between diabetes drugs like Byetta and pancreatic cancer (http://www.byettalawsuit.com/byetta-pancreatic-cancer/) continue to move forward in state and federal courts around the country, Bernstein Liebhard LLP...

2014-01-16 23:25:03

Allsup explains how severe thyroid diseases may qualify someone for Social Security Disability Insurance benefits. Belleville, IL (PRWEB) January 16, 2014 About 15 million people have thyroid diseases in the U.S., while another 15 million have yet to be diagnosed. These numbers highlight the importance of education during Thyroid Awareness Month in January, according to Allsup, which has helped hundreds of thousands of people receive their Social Security Disability Insurance (SSDI)...

2014-01-16 23:02:21

The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatic cancer, pancreatitis, or thyroid cancer, allegedly due to their use of Byetta. New York, New York (PRWEB) January 16, 2014 Byetta lawsuits (http://www.byettalawsuit.com), as well as product liability claims involving other incretin mimetic diabetes drugs, continue to mount in the federal multidistrict litigation now underway in U.S. District Court, Southern District of California, Bernstein...

2013-12-22 23:01:14

The attorneys at Bernstein Liebhard LLP are actively investigating potential Byetta lawsuit claims alleging pancreatic cancer, pancreatitis and thyroid cancer caused by the diabetes medication. (PRWEB) December 22, 2013 The federal litigation established for Byetta lawsuits (http://www.byettalawsuit2013.com/), which also includes claims brought by users of several other diabetes medications, continues to progress in the U.S. District Court, Southern District of California, Bernstein...

2013-12-16 16:25:49

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2013 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Cigna, one of the nation's leading providers of health insurance, has issued a positive coverage policy for the company's Afirma Gene Expression Classifier (GEC). The new policy applies to approximately 13 million of Cigna's medical customers and is effective immediately. The Afirma GEC is used to...

2013-12-03 23:02:19

The Firm is investigating potential Byetta lawsuits on behalf of alleged victims of Byetta and pancreatic cancer, pancreatitis and thyroid cancer. New York., NY (PRWEB) December 03, 2013 Byetta lawsuits (http://www.byettalawsuit2013.com/ ), as well as product liability claims involving other incretin mimetic diabetes drugs, continue to move forward in a multidistrict litigation now underway in U.S. District Court, Southern District of California. According to an Order issued on November...

2013-11-25 23:01:23

The Firm is now evaluating Byetta lawsuits that allege a link between the use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer. New York, New York (PRWEB) November 25, 2013 As Byetta lawsuit (http://www.byettalawsuit2013.com/ ) claims continue to mount in courts throughout the U.S., Bernstein Liebhard LLP notes the publication of a new study which supports an association between incretin mimetics like Byetta and pancreatic impairment, most notably pancreatitis....

2013-11-22 20:22:37

First and only FDA-approved treatment option for patients with this type of thyroid cancer WHIPPANY, N.J., THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Nov. 22, 2013 /PRNewswire/ -- Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq:AMGN), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR(®) (sorafenib) tablets for the treatment of patients...

2013-11-16 23:02:02

The Firm is currently investigating Byetta lawsuits that allege an association between use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer. New York, New York (PRWEB) November 16, 2013 Dozens of Byetta lawsuits, (http://www.byettalawsuit2013.com/) as well as other product liability claims involving Januvia, Victoza and other diabetes drugs known as incretin mimetics, continue to move forward in a federal multidistrict litigation now underway in U.S. District...